94 related articles for article (PubMed ID: 24761914)
1. The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.
Xia Y; Guo XG; Ji TX
Asian Pac J Cancer Prev; 2014; 15(6):2857-61. PubMed ID: 24761914
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
Shen W; Cao X; Xi L; Deng L
Mol Biol Rep; 2012 Feb; 39(2):2039-44. PubMed ID: 21643956
[TBL] [Abstract][Full Text] [Related]
3. The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.
Zhu K; Jiang B; Hu R; Yang Y; Miao M; Li Y; Liu Z
PLoS One; 2014; 9(9):e108953. PubMed ID: 25268356
[TBL] [Abstract][Full Text] [Related]
4. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer.
Kruszyna Ł; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
DNA Cell Biol; 2010 Aug; 29(8):423-7. PubMed ID: 20406099
[TBL] [Abstract][Full Text] [Related]
5. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.
Ma XY; Jin Y; Sun HM; Yu L; Bai J; Chen F; Fu SB
Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1702-8. PubMed ID: 22762525
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
[TBL] [Abstract][Full Text] [Related]
8. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
[TBL] [Abstract][Full Text] [Related]
9. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.
Meng D; Wu YX; Heerah V; Peng S; Chu MD; Xu YJ; Xiong WN; Xu SY
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):319-326. PubMed ID: 26072067
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor-1 G801A polymorphism and the risk factors for cervical cancer.
Roszak A; Misztal M; Sowińska A; Jagodziński PP
Mol Med Rep; 2015 Jun; 11(6):4633-8. PubMed ID: 25672413
[TBL] [Abstract][Full Text] [Related]
11. Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.
Alijanpour A; Golshan A; Vakili-Ojarood M; Shirinzadeh-Dastgiri A; Naseri A; Karimi-Zarchi M; Hajizadeh N; Barahman M; Azizi S; Aghasipour M; Khajehnoori S; Aghili K; Neamatzadeh H
Asian Pac J Cancer Prev; 2024 Mar; 25(3):767-776. PubMed ID: 38546059
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population.
Liu W; Zhu E; Wang R; Wang L; Liu T
Med Oncol; 2012 Jun; 29(2):677-81. PubMed ID: 21298365
[TBL] [Abstract][Full Text] [Related]
13. CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan.
Shi MD; Chen JH; Sung HT; Lee JS; Tsai LY; Lin HH
Arch Med Sci; 2013 Dec; 9(6):999-1005. PubMed ID: 24482642
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis.
Yang L; Li N; Wang S; Kong Y; Tang H; Xie X; Xie X
Asian Pac J Cancer Prev; 2014; 15(12):4823-7. PubMed ID: 24998547
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
16. Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects.
Zhang J; Zhang L; Li G
World J Surg Oncol; 2016 Aug; 14(1):230. PubMed ID: 27568010
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and the risk of breast carcinoma.
Zhong JH; Li LQ; Mo XS; Gong WF; Ma L; Chen J; You XM
Genet Mol Res; 2015 Apr; 14(2):4133-41. PubMed ID: 25966185
[TBL] [Abstract][Full Text] [Related]
18. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
[TBL] [Abstract][Full Text] [Related]
19. The Interleukin-18 promoter -607C>A polymorphism contributes to nasopharyngeal carcinoma risk: evidence from a meta-analysis including 1,886 subjects.
Guo XG; Xia Y
Asian Pac J Cancer Prev; 2013; 14(12):7577-81. PubMed ID: 24460336
[TBL] [Abstract][Full Text] [Related]
20. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
